Skip to main content

Want a detailed portfolio tracker?

Sana Biotechnology (SANA) P/E (2021 - 2026)

Sana Biotechnology (SANA) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Sana Biotechnology (SANA) P/E is -3.28. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Sana Biotechnology (SANA)

YearP/EChange
2026-3.28-18.80%
2025-4.04+197.41%
2024-1.36-52.57%
2023-2.86+16.05%
2022-2.47-68.75%
2021-7.90N/A

Comparison Sana Biotechnology (SANA) P/E with competitors

Sana Biotechnology (SANA) P/E is -3.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.28%
FGENFibroGen Inc0.24-107.32%
CHRSCoherus Biosciences Inc0.85-125.86%
FBIOFortress Biotech Inc0.95-128.92%
ORMPOramed Pharmaceuticals Inc1.50-145.81%
AGENAgenus Inc3.01-191.73%
INVAInnoviva Inc3.15-196.13%
VXRTVaxart Inc3.55-208.19%
CRMDCorMedix Inc3.63-210.59%
CVACCureVac N.V.4.45-235.49%
GLPGGalapagos NV4.86-248.09%
SRPTSarepta Therapeutics Inc4.88-248.79%
ABEOAbeona Therapeutics Inc5.39-264.20%
ABUSArbutus Biopharma Corp5.60-270.54%
ZVRAZevra Therapeutics Inc5.89-279.43%
SPROSpero Therapeutics Inc6.23-289.83%
CGENCompugen Ltd6.31-292.43%
RIGLRigel Pharmaceuticals6.87-309.44%
SLXNSilexion Therapeutics Corp7.30-322.37%
OMEROmeros Corporation9.26-382.19%
AUPHAurinia Pharmaceuticals Inc9.58-392.13%
PLXProtalix BioTherapeutics Inc10.89-431.93%
ACADAcadia Pharmaceuticals Inc11.73-457.46%
TBPHTheravance Biopharma Inc12.26-473.72%
ADMAAdma Biologics Inc12.42-478.48%
HRMYHarmony Biosciences Holdings Inc13.82-521.21%
NAGENiagen Bioscience Inc14.82-551.62%
INCYIncyte Corp15.82-582.24%
REGNRegeneron Pharmaceuticals Inc15.86-583.28%
PBYIPuma Biotechnology Inc17.32-627.74%
CPRXCatalyst Pharmaceuticals Inc17.44-631.51%
EXELExelixis Inc17.54-634.52%
TGTXTG Therapeutics Inc18.97-678.04%
MDXGMimedx Group Inc20.55-726.39%
XOMAXOMA Royalty Corp22.87-797.19%
ARGXArgen X SE24.30-840.57%
CTMXCytomX Therapeutics Inc24.82-856.51%
XOMAOXOMA Royalty Corp25.34-872.47%
HALOHalozyme Therapeutics Inc25.62-880.97%
XOMAPXOMA Royalty Corp25.67-882.39%
VRTXVertex Pharmaceuticals Inc27.99-953.24%
RPRXRoyalty Pharma plc - Class A28.69-974.36%
SLNOSoleno Therapeutics Inc29.02-984.35%
ASNDAscendis Pharma A/S30.09-1016.96%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1255.50%
APLSApellis Pharmaceuticals Inc39.02-1289.31%
BMRNBiomarin Pharmaceutical Inc42.21-1386.56%
KRYSKrystal Biotech Inc45.34-1482.00%
ONCBeiGene Ltd69.54-2219.49%
PHARPharming Group N.V.75.03-2386.67%
TECHBio-Techne Corp101.96-3207.55%
VCELVericel Corp109.92-3450.25%
ALNYAlnylam Pharmaceuticals Inc117.96-3695.41%
GMABGenmab140.29-4375.87%
TLXTelix Pharmaceuticals Ltd162.15-5042.19%
CORTCorcept Therapeutics Inc212.86-6587.60%